---
schema_version: "secwatch.filing_event.v1"
accession: "0001606757-26-000028"
form_type: "8-K"
ticker: "KE"
cik: "0001606757"
company_name: "Kimball Electronics, Inc."
filed_at: "2026-07-01T11:20:21+00:00"
generated_at: "2026-07-01T11:25:07.234033+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Kimball Electronics acquires Helvoet for €90M (~$103M); establishes global medical CDMO platform

## Summary
- Purchase price €90M (~$103M); funded with cash and existing credit lines; closed July 1, 2026.
- Helvoet is a medical CDMO specializing in micro-molding, microfluidics, diagnostics, drug delivery; 2025 revenue ~$56M, EBITDA margin mid-teens.
- Transaction valued at ~9x estimated 2026 adjusted EBITDA; expected to be accretive to fiscal 2027 adjusted earnings.
- Helvoet CEO Eveline Hogenkamp to remain; operations in Netherlands and India; complements Kimball's Indianapolis facility.
- Acquisition establishes global medical CMO platform; expands European and India footprint; blue-chip customer base.

## SEC filing metadata
- accession: 0001606757-26-000028
- form_type: 8-K
- ticker: KE
- cik: 0001606757
- company_name: Kimball Electronics, Inc.
- filed_at: 2026-07-01T11:20:21+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1606757/000160675726000028/0001606757-26-000028-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1606757/000160675726000028/ke-20260626.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001606757-26-000028
- JSON: https://secwatch.observer/filing/0001606757-26-000028.json
- Plain text: https://secwatch.observer/filing/0001606757-26-000028.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.